PVLA
Palvella Therapeutics
PVLA
PVLA
139 hedge funds and large institutions have $1.02B invested in Palvella Therapeutics in 2025 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 42 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
45% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 29
39% more funds holding
Funds holding: 100 → 139 (+39)
5.37% more ownership
Funds ownership: 77.09% → 82.45% (+5.4%)
Holders
139
Holding in Top 10
4
Calls
$20.2M
Puts
$10.2M
Top Buyers
| 1 | +$30.2M | |
| 2 | +$24.2M | |
| 3 | +$23.9M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$22.9M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$18M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$20.5M | |
| 3 | -$15.7M | |
| 4 |
Goldman Sachs
New York
|
-$11.7M |
| 5 |
PA
Perceptive Advisors
New York
|
-$11M |
